Delivering new insights to drive personalized trials

신장학

Collaborate with a board-certified nephrologist (who is also in academia), to ensure successful trial design and execution 

Engage Fortrea’s regulatory strategy and operational experts for data-driven planning

Leverage relationships with nephrology sites and trial stakeholders (such as Dialysis Organizations and Kidney Patient Advocacy Groups) to deliver timely diversity-focused recruitment

Experience matters when choosing a partner

In the last 5 years

178

Nephrology Studies

5,000+

Sites

23,000명+

환자

Top Indications

Why choose Fortrea for your next Nephrology trial?

  • Hear and apply our lessons learned across the different types of nephrology studies to understand the nuances of sites and recipe for successful trial execution in dialysis vs. rare kidney disease (e.g., Glomerular Disease) vs. common CKD (e.g., Diabetic Kidney Disease) patients
  • Benefit from our focused training specific to the needs of each type of nephrology study to address issues such as proper 24-hour urine collections, renal biomarker development, PRO collection and central lab monitoring
  • Harness the dedicated and overlapping expertise of our partners in Clinical Pharmacology Solutions and our Rare and Pediatric Disease colleagues

Renal Impairment Studies Rare Diseases

Get to know us

Barbara S. Gillespie, MD, MMS, FASN

Vice President & Therapeutic Strategy Leader
약력 보기

Your agile partner for comprehensive nephrology clinical trials

We bring extensive depth of expertise to nephrology therapeutic development. Once your trial is underway, you can rely on Fortrea’s clinical trial management team to provide close communication and collaboration. We use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.

1상에서 4상까지 아우르는 포괄적인 임상 실험 관리, 임상 약학, 환자 액세스 솔루션 및 기타 지원 서비스를 제공하는 Fortrea는 신흥·대형 바이오 제약회사, 의료 기기 및 진단 기업과 협력하고 있습니다.

최신 소식 받기:
Fortrea 뉴스 및 공지사항을 구독하세요.